Free weekly newsletter

Get the free weekly funding digest

The new funding rounds, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New funding rounds, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Industry Trends

See who's moving and how much in your market

No credit card required Weekly funding digest

Gallant Raises $15M for Pet Stem Cell Therapies

PRIVATEJan 30, 2024•over 2 years ago

Amount Raised

$15 Million

San DiegoOtherBiotechnologyHealth CareTherapeutics

Investors

Digitalis Ventures

Description

Gallant Therapeutics announced it had raised more than $15 million in Series A funding from a leading investor syndicate, enabling the company to further its mission to make U.S. Food and Drug Administration-approved, stem cell therapies a reality for pets.

Company Information

Company

Gallant

Location

10865 Road to the Cure, Ste 101

San Diego, California, United States

About

Gallant is a regenerative medicine company pioneering veterinary therapies that restore health at the source. We’re developing a pipeline of off-the-shelf mesenchymal stem cell (MSC) therapies to address chronic conditions in dogs and cats—including feline chronic gingivostomatitis (FCGS), osteoarthritis, chronic kidney disease, and atopic dermatitis. Our first product, based on a proprietary uterine-derived stem cell platform, is on track for conditional FDA approval in 2026. Led by industry pioneers in veterinary regenerative medicine, Gallant combines science, purpose, and compassion to help pets live healthier, more vibrant lives.

Related People

Suggested for you

1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Gallant's next move

Learn about Strategic plan

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Watching Gallant? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demo Choose your plan